Jennifer Loscher

Director, Regulatory Affairs, Biogen, United Kingdom

Professional Overview
Jennifer Loscher is an experienced regulatory affairs professional with a strong track record in the pharmaceutical industry. As the Director of Regulatory Affairs at Biogen, she oversees the development and implementation of regulatory strategies to support the company's global product portfolio. With her in-depth expertise in international regulatory frameworks and her ability to navigate complex regulatory environments, Jennifer plays a pivotal role in ensuring Biogen's products meet all relevant standards and guidelines.

Experience Summary

Current Role
Jennifer has served as the Director of Regulatory Affairs at Biogen since December 2020. In this role, she is responsible for leading a team of regulatory affairs specialists and managing the regulatory processes for Biogen's portfolio of biopharmaceutical products. She collaborates closely with cross-functional teams to develop and execute regulatory strategies that support the successful registration and commercialization of Biogen's products in various markets worldwide.

Career Progression
Prior to her current position, Jennifer held several regulatory affairs roles at Biogen, including Associate Director of European Regulatory Affairs and Associate Director of Global Emerging Markets Regulatory Affairs. In these previous positions, she demonstrated her ability to navigate complex regulatory landscapes and drive successful product approvals in both mature and emerging markets.

Before joining Biogen, Jennifer worked as a Senior Consultant at PAREXEL, where she provided regulatory expertise and strategic guidance to pharmaceutical and biotechnology clients. She also held regulatory affairs roles at Amdipharm and Bimeda, further honing her skills in international regulatory compliance and product registration.

Academic Background
Jennifer holds a bachelor's degree in Pharmaceutical Sciences from the University of Brighton.

Areas of Expertise

• Regulatory strategy development and implementation

• Global regulatory affairs management

• Navigating complex regulatory frameworks

• Stakeholder engagement and cross-functional collaboration

• Biopharma product registration and commercialization

• Compliance and risk management

Professional Impact
Throughout her career, Jennifer has played a pivotal role in securing successful product registrations and market authorizations for her employers. At Biogen, she has been instrumental in driving the company's regulatory strategy, ensuring the timely and compliant submission of applications across various international markets. Her contributions have directly supported Biogen's efforts to expand patient access to its innovative biopharmaceutical therapies.

Conclusion
With her extensive experience in the pharmaceutical industry and her deep expertise in regulatory affairs, Jennifer Loscher is a valuable asset to Biogen. Her strategic leadership and collaborative approach have made her a trusted partner in navigating the complex regulatory landscape, enabling the company to deliver its transformative therapies to patients worldwide.